RepliCel Life Sciences Inc. announced that Mr. Peter Lowry will not be standing for re-election as a director at the Meeting. The Board will appoint a new member to the NCCG Committee after the Meeting.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.0428 USD | +4.99% | -.--% | -4.89% |
May. 17 | RepliCel Life Sciences Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Apr. 18 | RepliCel Life Sciences Inc. Announces Secured Loan Agreement | CI |
1st Jan change | Capi. | |
---|---|---|
-4.89% | 2.78M | |
+8.56% | 114B | |
+12.65% | 107B | |
-12.83% | 22.22B | |
-2.01% | 21.28B | |
-5.29% | 18.8B | |
-5.53% | 17.51B | |
-39.93% | 17.17B | |
+6.03% | 14.14B | |
+33.06% | 12.2B |
- Stock Market
- Equities
- REPCF Stock
- News RepliCel Life Sciences Inc.
- Replicel Life Sciences Inc. Announces That Peter Lowry Will Not Be Standing for Re-Election as A Director